よむ、つかう、まなぶ。
医療機器研究報告 (148 ページ)
出典
| 公開元URL | https://www.mhlw.go.jp/stf/shingi2/0000190382_00011.html |
| 出典情報 | 薬事・食品衛生審議会 医療機器・再生医療等製品安全対策部会（令和4年度第1回 7／12）《厚生労働省》 |
ページ画像
ダウンロードした画像を利用する際は「出典情報」を明記してください。
低解像度画像をダウンロード
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
研究報告
番号
1323
1324
1325
1326
1327
1328
1329
1330
1331
医療機器の一般名
経カテーテルブタ心のう
膜弁
経カテーテルブタ心のう
膜弁
文献名
【Journal of the American College of Cardiology, VOL.78, NO.19, SUPPL B, 2021 B60】TCT-147 Transcatheter Aortic
Valve Replacement in Large Annuli Valves With the Supra-Annular, Self-Expandable Evolut Platform: Insights From the
STS/ACC TVT Registry
【Journal of the American College of Cardiology, VOL.78, NO.19, SUPPL B, 2021 B60】TCT-147 Transcatheter Aortic
Valve Replacement in Large Annuli Valves With the Supra-Annular, Self-Expandable Evolut Platform: Insights From the
STS/ACC TVT Registry
経カテーテルブタ心のう 【Journal of the American College of Cardiology, VOL.78, NO.19 ,SUPPL B, 2021 B59】TCT-143 Transfemoral Versus
膜弁
Alternative Access for Transcatheter Aortic Valve Replacement With Evolut Platform
経カテーテルブタ心のう 【Journal of the American College of Cardiology, VOL.78, NO.19 ,SUPPL B, 2021 B59】TCT-143 Transfemoral Versus
膜弁
Alternative Access for Transcatheter Aortic Valve Replacement With Evolut Platform
経カテーテルブタ心のう 【Journal of the American College of Cardiology, VOL.78, NO.19 ,SUPPL B, 2021 B59】TCT-143 Transfemoral Versus
膜弁
Alternative Access for Transcatheter Aortic Valve Replacement With Evolut Platform
経カテーテルブタ心のう 【Journal of the American College of Cardiology, 78(19 Suppl B):B23-B24, 2021】UPDATED CLINICAL AND
膜弁
PROCEDURAL OUTCOMES IN TAVR FOR BICUSPID VERSUS TRICUSPID AORTIC VALVE STENOSIS
経カテーテルブタ心のう 【Journal of the American College of Cardiology, VOL.78, NO.19, SUPPL B, 2021 B20】TCT-49 Incidence of Permanent
膜弁
経カテーテルブタ心のう
膜弁
経カテーテルブタ心のう
膜弁
Pacemaker Implantation Using the Cusp-Overlap Technique: A Large Single-Center Analysis
【Journal of the American College of Cardiology. VOL.78, NO.19, SUPPL B, 2021 B19】TCT-48 Incidence and Outcomes
of Atrial Fibrillation in Patients Undergoing TAVR Versus SAVR: Experience From SURTAVI and Low-Risk Randomized
Studies
【Journal of the American College of Cardiology. VOL.78, NO.19, SUPPL B, 2021 B19】TCT-48 Incidence and Outcomes
of Atrial Fibrillation in Patients Undergoing TAVR Versus SAVR: Experience From SURTAVI and Low-Risk Randomized
Studies
148 / 224
番号
1323
1324
1325
1326
1327
1328
1329
1330
1331
医療機器の一般名
経カテーテルブタ心のう
膜弁
経カテーテルブタ心のう
膜弁
文献名
【Journal of the American College of Cardiology, VOL.78, NO.19, SUPPL B, 2021 B60】TCT-147 Transcatheter Aortic
Valve Replacement in Large Annuli Valves With the Supra-Annular, Self-Expandable Evolut Platform: Insights From the
STS/ACC TVT Registry
【Journal of the American College of Cardiology, VOL.78, NO.19, SUPPL B, 2021 B60】TCT-147 Transcatheter Aortic
Valve Replacement in Large Annuli Valves With the Supra-Annular, Self-Expandable Evolut Platform: Insights From the
STS/ACC TVT Registry
経カテーテルブタ心のう 【Journal of the American College of Cardiology, VOL.78, NO.19 ,SUPPL B, 2021 B59】TCT-143 Transfemoral Versus
膜弁
Alternative Access for Transcatheter Aortic Valve Replacement With Evolut Platform
経カテーテルブタ心のう 【Journal of the American College of Cardiology, VOL.78, NO.19 ,SUPPL B, 2021 B59】TCT-143 Transfemoral Versus
膜弁
Alternative Access for Transcatheter Aortic Valve Replacement With Evolut Platform
経カテーテルブタ心のう 【Journal of the American College of Cardiology, VOL.78, NO.19 ,SUPPL B, 2021 B59】TCT-143 Transfemoral Versus
膜弁
Alternative Access for Transcatheter Aortic Valve Replacement With Evolut Platform
経カテーテルブタ心のう 【Journal of the American College of Cardiology, 78(19 Suppl B):B23-B24, 2021】UPDATED CLINICAL AND
膜弁
PROCEDURAL OUTCOMES IN TAVR FOR BICUSPID VERSUS TRICUSPID AORTIC VALVE STENOSIS
経カテーテルブタ心のう 【Journal of the American College of Cardiology, VOL.78, NO.19, SUPPL B, 2021 B20】TCT-49 Incidence of Permanent
膜弁
経カテーテルブタ心のう
膜弁
経カテーテルブタ心のう
膜弁
Pacemaker Implantation Using the Cusp-Overlap Technique: A Large Single-Center Analysis
【Journal of the American College of Cardiology. VOL.78, NO.19, SUPPL B, 2021 B19】TCT-48 Incidence and Outcomes
of Atrial Fibrillation in Patients Undergoing TAVR Versus SAVR: Experience From SURTAVI and Low-Risk Randomized
Studies
【Journal of the American College of Cardiology. VOL.78, NO.19, SUPPL B, 2021 B19】TCT-48 Incidence and Outcomes
of Atrial Fibrillation in Patients Undergoing TAVR Versus SAVR: Experience From SURTAVI and Low-Risk Randomized
Studies
148 / 224